Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
A curated entry point for buyers comparing quality, documentation, and availability
Lurasidone versus treatment as usual for cognitive impairment in euthymic patients with bipolar I disorder: a randomised, open-label, pilot study
The FDA does not approve compounded medications for safety, quality, or manufacturing
Scientists are finding that the drugs may be useful to treat addiction, dementia, and heart disease (CNBC)
US$ 20.86
US$ 23.36
US$ 23.03
US$ 27.92
US$ 21.97
US$ 20.59
US$ 24.37
US$ 24.53
US$ 21.91
